Prompt Response to single injection of Bevacizumab in a case of Fibrinous Central Serous Choroidopathy (CSC).

Authors

  • Balbir Khan Department of Ophthalmology, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab
  • Rajwinder Kaur Department of Ophthalmology, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab
  • Vartika Anand Department of Ophthalmology, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab
  • Prithpal S Matreja Department of Pharmacology, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab

DOI:

https://doi.org/10.3329/bjms.v16i1.31152

Keywords:

Central serous choroidopathy, visual function, fibrin, bevacizumab

Abstract

Purpose: Central Serous Choroidopathy (CSC) is a disease of young and middle aged adults as a localized detachment of the neurosensory retina. Though the cause of CSC remains unknown, it is believed that abnormalities in choroidal circulation make overlying retinal pigment epithelium dysfunctional, resulting in development of a serous retinal detachment. Subretinal fibrin accumulation is rare but vision threatening association of CSC.

Methods: A young 31 years female with acute central serous chorioretinopathy received an Intravitreal bevacizumab (1.25 mg/0.05 ml) injection. At baseline and follow-up visits, patients had best corrected visual acuity (BCVA), IOP assessment, dilated fundus examination, fundus photography, fluorescein angiography (FA), and Optical Coherence Topography(OCT) imaging.

Results: Patient showed resolution of fibrin, resolution of intraretinal or subretinal fluid promptly, and improvement in visual symptoms and acuity within 1 month. At 6 months patient is maintaining 20/20 vision without any recurrence.

Conclusions: Intravitreal bevacizumab injection for acute fibrinous central serous choroidopathy may result in prompt resolution of neurosensory detachment and reduction of angiographic leakage. These short-term results suggest that Intravitreal bevacizumab injection may constitute a promising therapeutic option in fibrinous central serous chorioretinopathy.

Bangladesh Journal of Medical Science Vol.16(1) 2017 p.157-160

Downloads

Abstract
31
PDF
31

Author Biography

Balbir Khan, Department of Ophthalmology, Gian Sagar Medical College and Hospital, Banur, Patiala, Punjab



Downloads

Published

2017-01-16

How to Cite

Khan, B., Kaur, R., Anand, V., & Matreja, P. S. (2017). Prompt Response to single injection of Bevacizumab in a case of Fibrinous Central Serous Choroidopathy (CSC). Bangladesh Journal of Medical Science, 16(1), 157–160. https://doi.org/10.3329/bjms.v16i1.31152

Issue

Vol. 16 No. 1 (2017)

Section

Case Reports

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.